Trials / Completed
CompletedNCT01025973
Evaluation and Validation of New Biomarkers by Mass Spectrometry
A New Approach by Mass Spectrometry for Evaluation and Validation of New Biomarkers of Fetus and Mother
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 99 (actual)
- Sponsor
- Université de Sherbrooke · Academic / Other
- Sex
- All
- Age
- 1 Day
- Healthy volunteers
- Accepted
Summary
The investigators will perform biochemical and metabolic evaluations on cord blood, venous blood of the mother and urine of the foetus and mother using time-of-flight and tandem mass spectrometry. The investigators could evaluate, dose and validate gestational diabetes mellitus biomarkers of the fetus and mother.
Conditions
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2011-05-01
- Completion
- 2013-02-01
- First posted
- 2009-12-04
- Last updated
- 2018-05-08
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01025973. Inclusion in this directory is not an endorsement.